{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:33:52Z","timestamp":1791221632820,"version":"4.1.0"},"reference-count":112,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,11,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>With the success of Phosphodiesterase (PDE) type 5 inhibitors (i.e., sildenafil, tadalafil, vardenafil) in the treatment of erectile dysfunction (ED), PDEs are considered attractive targets for drug intervention in the urogenital tract.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>To review the role of PDEs, which exist as a superfamily of enzymes comprising 11 distinct families, in the urogenital system, focusing on anatomical locations, functions and dysfunctions, potential disorders that could be treated, and any promising new selective PDE inhibitors under development.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Included are (i) abstracts from 2001, 2002, and 2003; (ii) a MEDLINE search from 1996 through December 2003; and (iii) a pipeline search for therapeutics in development. Data from animal experiments are presented when there is a paucity of human data, but with the caveat that the distribution of PDE isozymes in a specific tissue can vary between species.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>PDE mRNA and protein have been localized throughout the normal human urogenital tract. Double-blind, placebo-controlled studies suggest possible new clinical roles for sildenafil, including prophylaxis to preserve penile smooth muscle and erectile function after radical prostatectomy, and treatment of ejaculatory delay secondary to serotonergic reuptake inhibitor antidepressant therapy. Open-label studies suggest a potential clinical role for: vinpocetine (a PDE1 inhibitor) in the treatment of incontinence and low-compliance bladder; and sildenafil in the treatment of premature ejaculation, prostate-related lower urinary tract symptoms, and in women who have had unsuccessful in vitro fertilization. Several new orally administered PDE5 inhibitors are in early clinical development for the treatment of ED. Potential indications for PDE inhibitors that are suggested by preclinical data include Peyronie's disease, ureteral colic, male and female birth control, and prevention of preterm labor.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Drug selectivity and differential PDE tissue distribution allow for potential targeted intervention for numerous disorders related to the urogenital tract.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/j.1743-6109.04047.x","type":"journal-article","created":{"date-parts":[[2004,10,13]],"date-time":"2004-10-13T14:00:40Z","timestamp":1097676040000},"page":"322-336","source":"Crossref","is-referenced-by-count":31,"title":["Review of Phosphodiesterases in the Urogenital System: New Directions for Therapeutic Intervention"],"prefix":"10.1093","volume":"1","author":[{"given":"Francesco","family":"Montorsi","sequence":"first","affiliation":[{"name":"Department of Urology, Universit\u00e0 Vita Salute San Raffaele , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie","family":"Corbin","sequence":"additional","affiliation":[{"name":"Department of Molecular Physiology, Vanderbilt University School of Medicine , Nashville, TN , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Phillips","sequence":"additional","affiliation":[{"name":"Pfizer Global Research & Development , Sandwich , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2004,11,1]]},"reference":[{"issue":"20","key":"2024032600065129000_bib1","doi-asserted-by":"crossref","first-page":"13729","DOI":"10.1074\/jbc.274.20.13729","article-title":"Cyclic GMP phosphodiesterase-5: Target of sildenafil","volume":"274","author":"Corbin","year":"1999","journal-title":"J Biol Chem"},{"key":"2024032600065129000_bib2","first-page":"1","article-title":"Cyclic nucleotide phosphodiesterases: Relating structure and function","volume":"65","author":"Francis","year":"2001","journal-title":"Prog Nucl Acid Res Mol Bio"},{"key":"2024032600065129000_bib3","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1046\/j.1464-410X.1997.00206.x","article-title":"Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro","volume":"79","author":"Jeremy","year":"1997","journal-title":"Br J Urol"},{"key":"2024032600065129000_bib4","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/sj.ijir.3900726","article-title":"The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil","volume":"13","author":"Saenz de Tejada","year":"2001","journal-title":"Int J Impot Res"},{"issue":"Suppl","key":"2024032600065129000_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1569-9056(02)80240-8","article-title":"Selectivity of sildenafil and other phosphodiesterase type 5 (PDE5) inhibitors against all human phosphodiesterase families","volume":"1","author":"Gbekor","year":"2002","journal-title":"Eur Urol"},{"key":"2024032600065129000_bib6","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0090-4295(03)00131-6","article-title":"Nitric oxide and the lower urinary tract: Current concepts, future prospects","volume":"61","author":"Mamas","year":"2003","journal-title":"Urology"},{"key":"2024032600065129000_bib7","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJM199805143382001","article-title":"Oral sildenafil in the treatment of erectile dysfunction","volume":"338","author":"Goldstein","year":"1998","journal-title":"N Engl J Med"},{"key":"2024032600065129000_bib8","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/j.1939-4640.2002.tb02332.x","article-title":"Vardenafil for treatment of men with erectile dysfunction: Efficacy and safety in a randomized, double-blind, placebo-controlled trial","volume":"23","author":"Hellstrom","year":"2002","journal-title":"J Androl"},{"issue":"4 Part 1","key":"2024032600065129000_bib9","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/S0022-5347(05)64442-4","article-title":"Efficacy and safety of tadalafil for the treatment of erectile dysfunction: Results of integrated analyses","volume":"168","author":"Brock","year":"2002","journal-title":"J Urol"},{"key":"2024032600065129000_bib10","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0090-4295(02)02439-1","article-title":"Phosphodiesterases as therapeutic targets","volume":"61","author":"Lin","year":"2003","journal-title":"Urology"},{"key":"2024032600065129000_bib11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/PL00007090","article-title":"Phosphodiesterase isoenzymes as pharmacological targets in the treatment of male erectile dysfunction","volume":"19","author":"Uckert","year":"2001","journal-title":"World J Urol"},{"key":"2024032600065129000_bib12","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1095\/biolreprod.102.004952","article-title":"Specificity of the cyclic adenosine 3\u2032,5\u2032-monophosphate signal in granulosa cell function","volume":"67","author":"Conti","year":"2002","journal-title":"Biol Reprod"},{"issue":"1\u20132","key":"2024032600065129000_bib13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0303-7207(01)00686-4","article-title":"Role of cyclic nucleotide signaling in oocyte maturation","volume":"187","author":"Conti","year":"2002","journal-title":"Mol Cell Endocrinol"},{"issue":"3 Part 1","key":"2024032600065129000_bib14","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0022-5347(05)67331-4","article-title":"Rabbit corpus cavernosum smooth muscle shows a different phosphodiesterase profile than human corpus cavernosum","volume":"164","author":"Qiu","year":"2000","journal-title":"J Urol"},{"key":"2024032600065129000_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/35.1.3025290","article-title":"Distribution of phosphodiesterase I in normal human tissues","volume":"35","author":"Morley","year":"1987","journal-title":"J Histochem Cytochem"},{"key":"2024032600065129000_bib16","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/BF00191209","article-title":"Characterization of cyclic nucleotide phosphodiesterase isoenzymes in the human ureter and their functional role in vitro","volume":"12","author":"Taher","year":"1994","journal-title":"World J Urol"},{"issue":"3 Part 1","key":"2024032600065129000_bib17","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0022-5347(01)62833-7","article-title":"The effect of the specific phosphodiesterase-IV-inhibitor rolipram on the ureteral peristalsis of the rabbit in vitro and in vivo","volume":"160","author":"Becker","year":"1998","journal-title":"J Urol"},{"key":"2024032600065129000_bib18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s002400050147","article-title":"Relaxation of human ureteral smooth muscle in vitro by modulation of cyclic nucleotide-dependent pathways","volume":"28","author":"Kuhn","year":"2000","journal-title":"Urol Res"},{"key":"2024032600065129000_bib19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1023\/A:1015196125469","article-title":"Effect of inhibitors of cyclic nucleotide phosphodiesterases on electrical and contractile activity of smooth muscle cells","volume":"133","author":"Kovalev","year":"2002","journal-title":"Bull Exp Biol Med"},{"key":"2024032600065129000_bib20","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1016\/S0022-5347(05)65621-2","article-title":"Characterization and functional relevance of cyclic nucleotide phosphodiesterase isoenzymes of the human prostate","volume":"166","author":"Uckert","year":"2001","journal-title":"J Urol"},{"key":"2024032600065129000_bib21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF00304074","article-title":"Cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human detrusor smooth muscle. I. Identification and characterization","volume":"24","author":"Truss","year":"1996","journal-title":"Urol Res"},{"issue":"suppl 5","key":"2024032600065129000_bib22","first-page":"131","article-title":"The effect of adenylate and guanylate cyclase activators, phosphodiesterase inhibitors, and protein kinase activators on normal human detrusor in vitro [Abstract]","volume":"39","author":"Truss","year":"2001","journal-title":"Eur Urol"},{"key":"2024032600065129000_bib23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/PL00007088","article-title":"Initial clinical experience with the selective phosphodiesterase-I isoenzyme inhibitor vinpocetine in the treatment of urge incontinence and low compliance bladder","volume":"18","author":"Truss","year":"2000","journal-title":"World J Urol"},{"key":"2024032600065129000_bib24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1748-1716.1993.tb09578.x","article-title":"Immunohistochemical localization of peripheral nitric oxide synthase-containing nerves using antibodies raised against synthesized C- and N-terminal fragments of a cloned enzyme from rat brain","volume":"148","author":"Alm","year":"1993","journal-title":"Acta Physiol Scand"},{"key":"2024032600065129000_bib25","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/BF00191207","article-title":"Nitric oxide synthase and nitric oxide-mediated effects in lower urinary tract smooth muscles","volume":"12","author":"Andersson","year":"1994","journal-title":"World J Urol"},{"issue":"2 Part 2","key":"2024032600065129000_bib26","first-page":"F226","article-title":"Adrenergic- and capsaicin-evoked nitric oxide release from urothelium and afferent nerves in urinary bladder","volume":"275","author":"Birder","year":"1998","journal-title":"Am J Physiol"},{"key":"2024032600065129000_bib27","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1177\/002215549904700603","article-title":"Morphological and biochemical investigation of nitric oxide synthase and related enzymes in the rat and pig urothelium","volume":"47","author":"Persson","year":"1999","journal-title":"J Histochem Cytochem"},{"key":"2024032600065129000_bib28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0014-2999(00)00457-X","article-title":"Nitric oxide-induced cGMP accumulation in the mouse bladder is not related to smooth muscle relaxation","volume":"401","author":"Fujiwara","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"2024032600065129000_bib29","doi-asserted-by":"crossref","first-page":"R1112","DOI":"10.1152\/ajpregu.2000.279.3.R1112","article-title":"Functional characteristics of urinary tract smooth muscles in mice lacking cGMP protein kinase type I","volume":"279","author":"Persson","year":"2000","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2024032600065129000_bib30","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1464-410X.1989.tb05280.x","article-title":"Is the treatment of urgency incontinence a placebo response? Results of a five-year follow-up","volume":"64","author":"Aitchison","year":"1989","journal-title":"Br J Urol"},{"key":"2024032600065129000_bib31","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1006\/bbrc.1998.9206","article-title":"Sildenafil inhibits phosphodiesterase type 5 in human clitoral corpus cavernosum smooth muscle","volume":"249","author":"Park","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"issue":"Suppl","key":"2024032600065129000_bib32","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S1569-9056(03)80468-2","article-title":"Immunohistochemical presence of cyclic AMP- and cyclic GMP- phosphodiesterase isoenzymes in human clitoris [Abstract]","volume":"2","author":"Uckert","year":"2003","journal-title":"Eur Urol"},{"key":"2024032600065129000_bib33","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0090-4295(02)01663-1","article-title":"Type 5 phosphodiesterase expression in the human vagina","volume":"60","author":"D\u2019Amati","year":"2002","journal-title":"Urology"},{"key":"2024032600065129000_bib34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/mcbr.1999.0164","article-title":"Development of human and rabbit vaginal smooth muscle cell cultures: Effects of vasoactive agents on intracellular levels of cyclic nucleotides","volume":"2","author":"Traish","year":"1999","journal-title":"Mol Cell Biol Res Commun"},{"key":"2024032600065129000_bib35","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1089\/152460902317585994","article-title":"The enhancement of vaginal vasocongestion by sildenafil in healthy premenopausal women","volume":"11","author":"Laan","year":"2002","journal-title":"J Womens Health Gend Based Med"},{"key":"2024032600065129000_bib36","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0090-4295(98)00633-5","article-title":"Safety and efficacy of sildenafil in postmenopausal women with sexual dysfunction","volume":"53","author":"Kaplan","year":"1999","journal-title":"Urology"},{"key":"2024032600065129000_bib37","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/713846821","article-title":"The use of the Female Intervention Efficacy Index (FIEI) as an immediate outcome measure of medical intervention to treat female sexual dysfunction","volume":"27","author":"Berman","year":"2001","journal-title":"J Sex Marital Ther"},{"key":"2024032600065129000_bib38","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/713846815","article-title":"Effect of sildenafil on subjective and physiologic parameters of the female sexual response in women with sexual arousal disorder","volume":"27","author":"Berman","year":"2001","journal-title":"J Sex Marital Ther"},{"key":"2024032600065129000_bib39","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/713846808","article-title":"Pharmacotherapy or psychotherapy?: Effective treatment for FSD related to unresolved childhood sexual abuse","volume":"27","author":"Berman","year":"2001","journal-title":"J Sex Marital Ther"},{"key":"2024032600065129000_bib40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/152460902317586001","article-title":"Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder","volume":"11","author":"Basson","year":"2002","journal-title":"J Womens Health Gend Based Med"},{"issue":"Suppl","key":"2024032600065129000_bib41","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1569-9056(03)80377-9","article-title":"A randomised double-blind, cross-over, placebo-controlled trial of Viagra in neurogenic female sexual dysfunction [Abstract]","volume":"2","author":"Dasgupta","year":"2003","journal-title":"Eur Urol"},{"key":"2024032600065129000_bib42","first-page":"623","article-title":"Premenopausal women affected by sexual arousal disorder treated with sildenafil: A double-blind, cross-over, placebo-controlled study","volume":"108","author":"Caruso","year":"2001","journal-title":"Br J Obs Gynaecol"},{"key":"2024032600065129000_bib43","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1095\/biolreprod66.1.180","article-title":"Effect of type 3 and type 4 phosphodiesterase inhibitors on the maintenance of bovine oocytes in meiotic arrest","volume":"66","author":"Mayes","year":"2002","journal-title":"Biol Reprod"},{"key":"2024032600065129000_bib44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1006\/dbio.2002.0609","article-title":"Differential effects of specific phosphodiesterase isoenzyme inhibitors on bovine oocyte meiotic maturation","volume":"244","author":"Thomas","year":"2002","journal-title":"Dev Biol"},{"key":"2024032600065129000_bib45","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1095\/biolreprod65.5.1444","article-title":"Role of phosphodiesterase type 3A in rat oocyte maturation","volume":"65","author":"Richard","year":"2001","journal-title":"Biol Reprod"},{"issue":"21","key":"2024032600065129000_bib46","doi-asserted-by":"crossref","first-page":"11998","DOI":"10.1073\/pnas.96.21.11998","article-title":"Impaired growth and fertility of cAMP-specific phosphodiesterase PDE4D-deficient mice","volume":"96","author":"Jin","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024032600065129000_bib47","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1210\/me.2002-0435","article-title":"Phosphodiesterase regulation is critical for the differentiation and pattern of gene expression in granulosa cells of the ovarian follicle","volume":"17","author":"Park","year":"2003","journal-title":"Mol Endocrinol"},{"key":"2024032600065129000_bib48","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1073\/pnas.97.1.472","article-title":"Cloning and characterization of PDE7B, a cAMP-specific phosphodiesterase","volume":"97","author":"Hetman","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"15","key":"2024032600065129000_bib49","doi-asserted-by":"crossref","first-page":"8991","DOI":"10.1073\/pnas.95.15.8991","article-title":"Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase","volume":"95","author":"Soderling","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024032600065129000_bib50","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1006\/bbrc.1998.8684","article-title":"Isolation and characterization of PDE8A, a novel human cAMP-specific phosphodiesterase","volume":"246","author":"Fisher","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"2024032600065129000_bib51","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0898-6568(94)90087-6","article-title":"Isolation and characterization of the rolipram-sensitive cyclic AMP-specific phosphodiesterase (type IV PDE) in human term myometrium","volume":"6","author":"Leroy","year":"1994","journal-title":"Cell Signal"},{"key":"2024032600065129000_bib52","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1074\/jbc.M106562200","article-title":"Regulation of cGMP-specific phosphodiesterase (PDE5) phosphorylation in smooth muscle cells","volume":"277","author":"Rybalkin","year":"2002","journal-title":"J Biol Chem"},{"key":"2024032600065129000_bib53","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0898-6568(98)00028-X","article-title":"Effect of pregnancy on PDE4 cAMP-specific phosphodiesterase messenger ribonucleic acid expression in human myometrium","volume":"11","author":"Leroy","year":"1999","journal-title":"Cell Signal"},{"key":"2024032600065129000_bib54","first-page":"817","article-title":"Pregnancy induces a modulation of the cAMP phosphodiesterase 4-conformers ratio in human myometrium: Consequences for the utero-relaxant effect of PDE4-selective inhibitors","volume":"292","author":"Mehats","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"2024032600065129000_bib55","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0006-2952(89)90142-1","article-title":"Correlation between selective inhibition of the cyclic nucleotide phosphodiesterases and the contractile activity in human pregnant myometrium near term","volume":"38","author":"Leroy","year":"1989","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"2024032600065129000_bib56","first-page":"5358","article-title":"Is up-regulation of phosphodiesterase 4 activity by PGE2 involved in the desensitization of beta-mimetics in late pregnancy human myometrium?","volume":"86","author":"Mehats","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032600065129000_bib57","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0014-2999(01)01351-6","article-title":"Sildenafil inhibits agonist-evoked rat uterine contractility: Influence of guanylyl cyclase inhibition","volume":"428","author":"Agha","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"2024032600065129000_bib58","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/humrep\/15.4.806","article-title":"Vaginal sildenafil (Viagra): A preliminary report of a novel method to improve uterine artery blood flow and endometrial development in patients undergoing IVF","volume":"15","author":"Sher","year":"2000","journal-title":"Hum Reprod"},{"key":"2024032600065129000_bib59","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0015-0282(02)03375-7","article-title":"Effect of vaginal sildenafil on the outcome of in vitro fertilization (IVF) after multiple IVF failures attributed to poor endometrial development","volume":"78","author":"Sher","year":"2002","journal-title":"Fertil Steril"},{"key":"2024032600065129000_bib60","first-page":"138","article-title":"Sildenafil citrate helps treat a severe case of dysmenorrhea","volume":"15","author":"Brincat","year":"2003","journal-title":"It J Gynaecol Obstet"},{"key":"2024032600065129000_bib61","first-page":"CD002860","article-title":"Nitric oxide donors for the treatment of preterm labor","volume":"2002","author":"Duckitt","journal-title":"Cochrane Database Syst Rev"},{"key":"2024032600065129000_bib62","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000020262","article-title":"Gene expression of the phosphodiesterases 3A and 5A in human corpus cavernosum penis","volume":"38","author":"Kuthe","year":"2000","journal-title":"Eur Urol"},{"issue":"suppl","key":"2024032600065129000_bib63","first-page":"314","article-title":"Histochemical presence of cyclic AMP phosphodiesterases and the protein kinase A in human penile erectile tissue [Abstract]","volume":"169","author":"Uckert","year":"2003","journal-title":"J Urol"},{"key":"2024032600065129000_bib64","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/S0022-5347(05)68249-3","article-title":"Potentiation of erectile response and cAMP accumulation by combination of prostaglandin E1 and rolipram, a selective inhibitor of the type 4 phosphodiesterase (PDE 4)","volume":"162","author":"Bivalacqua","year":"1999","journal-title":"J Urol"},{"issue":"suppl","key":"2024032600065129000_bib65","first-page":"223","article-title":"Cellular localisation of phosphodiesterase type 11 (PDE11) in human corpus cavernosum and the contribution of PDE11 inhibition on nerve-stimulated relaxation [Abstract]","volume":"165","author":"Baxendale","year":"2001","journal-title":"J Urol"},{"key":"2024032600065129000_bib66","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/S0022-5347(01)63622-X","article-title":"The effect of the specific phosphodiesterase (PDE) inhibitors on human and rabbit cavernous tissue in vitro and in vivo","volume":"159","author":"Stief","year":"1998","journal-title":"J Urol"},{"issue":"1\u20132","key":"2024032600065129000_bib67","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0014-2999(02)01621-7","article-title":"Relaxation induced by milrinone and rolipram in human penile arteries and veins","volume":"444","author":"Segarra","year":"2002","journal-title":"Eur J Pharmacol"},{"issue":"suppl","key":"2024032600065129000_bib68","first-page":"307","article-title":"Effect of phosphodiesterase (PDE) inhibitors on collagen synthesis and cell differentiation in fibroblast cultures from the Peyronie's disease plaque [Abstract]","volume":"169","author":"Vernet","year":"2003","journal-title":"J Urol"},{"issue":"suppl 2B","key":"2024032600065129000_bib69","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0090-4295(02)01687-4","article-title":"The efficacy of sildenafil citrate (Viagra\u00ae) in clinical populations: An update","volume":"60","author":"Carson","year":"2002","journal-title":"Urology"},{"key":"2024032600065129000_bib70","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1185\/030079903125001839","article-title":"Sildenafil in erectile dysfunction: A critical review","volume":"19","author":"Salonia","year":"2003","journal-title":"Curr Med Res Opin"},{"key":"2024032600065129000_bib71","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1046\/j.1464-410X.2003.04093.x","article-title":"Pharmacological management of erectile dysfunction","volume":"91","author":"Montorsi","year":"2003","journal-title":"BJU Int"},{"issue":"suppl 1","key":"2024032600065129000_bib72","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1038\/sj.ijir.3900796","article-title":"Vardenafil: Update on clinical experience","volume":"14","author":"Pryor","year":"2002","journal-title":"Int J Impot Res"},{"issue":"suppl 1","key":"2024032600065129000_bib73","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1038\/sj.ijir.3900807","article-title":"IC351 (tadalafil, Cialis): Update on clinical experience","volume":"14","author":"Porst","year":"2002","journal-title":"Int J Impot Res"},{"key":"2024032600065129000_bib74","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrd893","article-title":"Phosphodiesterase 5 inhibitors: Current status and potential applications","volume":"1","author":"Rotella","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"2024032600065129000_bib75","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1021\/jm0256068","article-title":"Substituted pyrazolopyridopyridazines as orally bioavailable potent and selective PDE5 inhibitors: Potential agents for treatment of erectile dysfunction","volume":"46","author":"Yu","year":"2003","journal-title":"J Med Chem"},{"issue":"21","key":"2024032600065129000_bib76","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1016\/S0960-894X(02)00646-7","article-title":"Design and synthesis of xanthine analogues as potent and selective PDE5 inhibitors","volume":"12","author":"Wang","year":"2002","journal-title":"Bioorg Med Chem Lett"},{"key":"2024032600065129000_bib77","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/S0022-5347(01)64227-7","article-title":"Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: Results of a prospective, randomized trial","volume":"158","author":"Montorsi","year":"1997","journal-title":"J Urol"},{"key":"2024032600065129000_bib78","first-page":"47","article-title":"Sildenafil: An orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction","volume":"8","author":"Boolell","year":"1996","journal-title":"Int J Impot Res"},{"issue":"2 Part 1","key":"2024032600065129000_bib79","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.ju.0000106970.97082.61","article-title":"Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy","volume":"171","author":"Schwartz","year":"2004","journal-title":"J Urol"},{"issue":"suppl","key":"2024032600065129000_bib80","first-page":"375","article-title":"Postoperative nightly administration of sildenafil citrate significantly improves the return of normal spontaneous erectile function after bilateral nerve-sparing radical prostatectomy [Abstract]","volume":"169","author":"Padma-Nathan","year":"2003","journal-title":"J Urol"},{"issue":"suppl 5","key":"2024032600065129000_bib81","first-page":"16","article-title":"Early use of antioxidants and phosphodiesterase inhibitors (PDE-) improve the return of erectile function after radical cystoprostatectomy (RCP) [Abstract]","volume":"39","author":"Khairy","year":"2001","journal-title":"Eur Urol"},{"key":"2024032600065129000_bib82","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/oxfordjournals.pubmed.a024665","article-title":"Sexual dysfunction in primary medical care: Prevalence, characteristics and detection by the general practitioner","volume":"19","author":"Read","year":"1997","journal-title":"J Public Health Med"},{"key":"2024032600065129000_bib83","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0090-4295(02)02075-7","article-title":"Efficacy of sildenafil as adjuvant therapy to selective serotonin reuptake inhibitor in alleviating premature ejaculation","volume":"61","author":"Chen","year":"2003","journal-title":"Urology"},{"issue":"suppl","key":"2024032600065129000_bib84","first-page":"378","article-title":"The effect of sildenafil citrate in the treatment of secondary rapid ejaculation [Abstract]","volume":"169","author":"Lobik","year":"2003","journal-title":"J Urol"},{"issue":"suppl","key":"2024032600065129000_bib85","first-page":"247","article-title":"Premature ejaculation: Sildenafil plus sertraline versus sertraline alone and sildenafil alone [Abstract]","volume":"169","author":"Lozano","year":"2003","journal-title":"J Urol"},{"key":"2024032600065129000_bib86","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.289.1.56","article-title":"Treatment of antidepressant-associated sexual dysfunction with sildenafil: A randomized controlled trial","volume":"289","author":"Nurnberg","year":"2003","journal-title":"JAMA"},{"issue":"suppl","key":"2024032600065129000_bib87","first-page":"376","article-title":"Discriminating treatment effects of sildenafil on orgasm delay and erectile dysfunction in serotonergic antidepressant-associated sexual dysfunction [Abstract]","volume":"169","author":"Nurnberg","year":"2003","journal-title":"J Urol"},{"key":"2024032600065129000_bib88","doi-asserted-by":"crossref","first-page":"721","DOI":"10.4088\/JCP.v64n0616","article-title":"High-dose sildenafil citrate for selective serotonin reuptake inhibitor-associated ejaculatory delay: Open clinical trial","volume":"64","author":"Seidman","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"2024032600065129000_bib89","volume-title":"Full prescribing information","author":"Levitra\u00ae (vardenafil, Bayer Pharmaceuticals Corporation, West Haven, CT)","year":"2003"},{"key":"2024032600065129000_bib90","volume-title":"Full prescribing information","author":"Cialis\u00ae (tadalafil, Lilly ICOS LLC, Indianapolis, IN)","year":"2003"},{"key":"2024032600065129000_bib91","volume-title":"Full prescribing information","author":"Viagra\u00ae (sildenafil citrate, Pfizer Inc., New York, NY","year":"2003"},{"key":"2024032600065129000_bib92","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1073\/pnas.97.7.3702","article-title":"Molecular cloning and characterization of a distinct human phosphodiesterase gene family:","volume":"97","author":"Fawcett","year":"2000","journal-title":"PDE11A. Proc Natl Acad Sci USA"},{"issue":"40","key":"2024032600065129000_bib93","doi-asserted-by":"crossref","first-page":"31469","DOI":"10.1074\/jbc.M003041200","article-title":"Isolation and characterization of two novel phosphodiesterase PDE11A variants showing unique structure and tissue-specific expression","volume":"275","author":"Yuasa","year":"2000","journal-title":"J Biol Chem"},{"issue":"Suppl","key":"2024032600065129000_bib94","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1569-9056(03)80075-1","article-title":"Histochemical distribution of phosphodiesterase isoenzymes 3, 4, and 5 in the human prostate [Abstract]","volume":"2","author":"Uckert","year":"2003","journal-title":"Eur Urol"},{"issue":"suppl","key":"2024032600065129000_bib95","first-page":"286","article-title":"Effects of phosphodiesterase inhibitors and nitric oxide donors on cultured human prostatic smooth muscle cells [Abstract]","volume":"169","author":"Heuer","year":"2003","journal-title":"J Urol"},{"key":"2024032600065129000_bib96","first-page":"375","article-title":"Assessment of the impact of sildenafil citrate on lower urinary tract symptoms (LUTS) in men with erectile dysfunction (ED) [Abstract]","volume":"169","author":"Hopps","year":"2003","journal-title":"J Urol"},{"key":"2024032600065129000_bib97","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1046\/j.1464-410X.2002.03040.x","article-title":"Sildenafil influences lower urinary tract symptoms","volume":"90","author":"Sairam","year":"2002","journal-title":"BJU Int"},{"key":"2024032600065129000_bib98","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0167-4781(97)00080-8","article-title":"Multiple splice variants of phosphodiesterase PDE4C cloned from human lung and testis","volume":"1353","author":"Obernolte","year":"1997","journal-title":"Biochim Biophys Acta"},{"issue":"27","key":"2024032600065129000_bib99","doi-asserted-by":"crossref","first-page":"18370","DOI":"10.1016\/S0021-9258(18)55280-7","article-title":"Properties and hormonal regulation of two structurally related cAMP phosphodiesterases from the rat Sertoli cell","volume":"266","author":"Swinnen","year":"1991","journal-title":"J Biol Chem"},{"key":"2024032600065129000_bib100","first-page":"839","article-title":"Characterization of an intronic promoter of a cyclic adenosine 3\u2032,5\u2032-monophosphate (cAMP)-specific phosphodiesterase gene that confers hormone and cAMP inducibility","volume":"11","author":"Vicini","year":"1997","journal-title":"Mol Endocrinol"},{"key":"2024032600065129000_bib101","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/humrep\/13.5.1248","article-title":"Enhancement of motility and acrosome reaction in human spermatozoa: Differential activation by type-specific phosphodiesterase inhibitors","volume":"13","author":"Fisch","year":"1998","journal-title":"Hum Reprod"},{"key":"2024032600065129000_bib102","first-page":"55","article-title":"Multiple roles of the messenger molecule cGMP in testicular function","volume":"32","author":"Middendorff","year":"2000","journal-title":"Andrologia"},{"issue":"suppl","key":"2024032600065129000_bib103","first-page":"340","article-title":"Phosphodiesterase type 11 (PDE11) cellular localisation: Progress towards defining a physiological role in testis and\/or reproduction [Abstract]","volume":"165","author":"Baxendale","year":"2001","journal-title":"J Urol"},{"issue":"suppl 3","key":"2024032600065129000_bib104","first-page":"S16","article-title":"Ablation of phosphodiesterase type 11 (PDE11) in mice by gene knockout induces changes in spermatozoa function [Abstract]","volume":"14","author":"Lunny","year":"2002","journal-title":"Int J Imp Res"},{"key":"2024032600065129000_bib105","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1046\/j.1365-2605.1999.00194.x","article-title":"Relationship between the proportion of capacitated spermatozoa present in frozen-thawed bull semen and fertility with artificial insemination","volume":"22","author":"Thundathil","year":"1999","journal-title":"Int J Androl"},{"key":"2024032600065129000_bib106","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/humrep\/15.1.131","article-title":"Effects of sildenafil (Viagra) administration on seminal parameters and post-ejaculatory refractory time in normal males","volume":"15","author":"Aversa","year":"2000","journal-title":"Hum Reprod"},{"key":"2024032600065129000_bib107","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/sj.ijir.3900551","article-title":"The effect of sildenafil on human sperm motion and function from normal and infertile men","volume":"12","author":"Burger","year":"2000","journal-title":"Int J Impot Res"},{"issue":"1172","key":"2024032600065129000_bib108","first-page":"101","article-title":"Tadalafil (Cialis) for erectile dysfunction","volume":"45","year":"2003","journal-title":"Med Lett Drugs Ther"},{"key":"2024032600065129000_bib109","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-1-59259-748-2_6","article-title":"Sildenafil and the NO\/cGMP signaling pathway","author":"Osterloh","year":"2004","journal-title":"Heart disease and erectile dysfunction"},{"key":"2024032600065129000_bib110","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00005392-200101000-00079","article-title":"Expression of different phosphodiesterase genes in human cavernous smooth muscle","volume":"165","author":"Kuthe","year":"2001","journal-title":"J Urol"},{"key":"2024032600065129000_bib111","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0009-2797(99)00074-5","article-title":"Molecular biological characterization of phosphodiesterase 3A from human corpus cavernosum","volume":"119\u2013120","author":"Kuthe","year":"1999","journal-title":"Chem Biol Interact"},{"key":"2024032600065129000_bib112","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1006\/bbrc.2000.2187","article-title":"Expression of three isoforms of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in human penile cavernosum","volume":"268","author":"Lin","year":"2000","journal-title":"Biochem Biophys Res Commun"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S174360951531081X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S174360951531081X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/1\/3\/322\/47522199\/jsm_1_3_322.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/1\/3\/322\/47522199\/jsm_1_3_322.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T01:04:36Z","timestamp":1711415076000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/1\/3\/322\/6863009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,1]]},"references-count":112,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2004,11,1]]},"published-print":{"date-parts":[[2004,11,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.04047.x","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2004,11]]},"published":{"date-parts":[[2004,11,1]]}}}